Aslan Pharmaceuticals Ltd
Change company Symbol lookup
Select an option...
ASLN Aslan Pharmaceuticals Ltd
CARR Carrier Global Corp
BRK.B Berkshire Hathaway Inc
PRA ProAssurance Corp
CAJFF Canon Inc
INSG Inseego Corp
LVRLF CordovaCann Corp
SRNE Sorrento Therapeutics Inc
JWN Nordstrom Inc
BKKXF Bangkok Expressway and Metro PCL
Go

Health Care : Biotechnology |
Based in Singapore
Company profile

ASLAN Pharmaceuticals Limited (ASLAN) is a clinical-stage immunology and oncology-focused biopharmaceutical company. ASLAN has a clinical portfolio comprised of a first in class monoclonal therapy, ASLAN004, that is being developed in atopic dermatitis and other immunology indications, and a small molecule inhibitor targeting oncology.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Price
Delayed
$1.87
Day's Change
0.05 (2.75%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.88
Day's Low
1.82
Volume
(Heavy Day)

Today's volume of 80,628 shares is on pace to be much greater than ASLN's 10-day average volume of 161,201 shares.

80,628
  • Prev Close
    1.82
  • Today's Open
    1.84
  • Day's Range
    1.82-1.88
  • Avg Vol (10-day)
    161.2K
  • Last (time)
    11:59a ET 11/25/20
  • Last (size)
    1
  • 52-Wk Range
    0.83 - 8.18
    LowHigh
  • (12/02/19 - 03/19/20)
    125.30%
  • 138.9%
  • Market Cap
    71.0M
  • Shares Outstanding
    38.0M
  • -1.31
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 10.63
  • (% of float 11/15/20)
    0.71

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.